Valeant Pharmaceuticals Scandal Exposes Systematic Price Gouging Strategy - 3000% Increase on Syprine, Philidor Fraud Network
Valeant Pharmaceuticals’ October 2015 disclosure of its relationship with specialty pharmacy Philidor Rx Services triggered the unraveling of a systematic drug price gouging scheme that had raised prices on dozens of medications by 50-3000% over two years. Under CEO Michael Pearson, Valeant …
Valeant Pharmaceuticals
J. Michael Pearson
Philidor Rx Services
William Ackman
Securities and Exchange Commission (SEC)
+2 more
pharmaceutical-industry
drug-pricing
healthcare
corporate-fraud
systematic-corruption
+1 more
Read more →